Literature DB >> 29270644

Preoperative multiparametric MRI of the prostate for the prediction of lymph node metastases in prostate cancer patients treated with extended pelvic lymph node dissection.

Giorgio Brembilla1,2, Paolo Dell'Oglio3,4, Armando Stabile3,4, Alessandro Ambrosi5, Giulia Cristel6,3, Lisa Brunetti6,3, Anna Damascelli6,3, Massimo Freschi7, Antonio Esposito6,3, Alberto Briganti3,4, Francesco Montorsi3,4, Alessandro Del Maschio6,3, Francesco De Cobelli6,3.   

Abstract

OBJECTIVES: To assess the role of preoperative multiparametric MRI (mpMRI) of the prostate in the prediction of nodal metastases in patients treated with radical prostatectomy (RP) and extended pelvic lymph node dissection (ePLND).
METHODS: We retrospectively analyzed 101 patients who underwent both preoperative mpMRI of the prostate and RP with ePLND at our institution. For each patient, complete preoperative clinical data and tumour characteristics at mpMRI were recorded. Final histopathologic stage was considered the standard of reference. Univariate and multivariate logistic regression analyses were performed.
RESULTS: Nodal metastases were found in 23/101 (22.8%) patients. At univariate analyses, all clinical and radiological parameters were significantly associated to nodal invasion (all p<0.03); tumour volume at MRI (mrV), tumour ADC and tumour T-stage at MRI (mrT) were the most accurate predictors (AUC = 0.93, 0.86 and 0.84, respectively). A multivariate model including PSA levels, primary Gleason grade, mrT and mrV showed high predictive accuracy (AUC = 0.956). Observed prevalence of nodal metastases was very low among tumours with mrT2 stage and mrV<1cc (1.8%).
CONCLUSION: Preoperative mpMRI of the prostate can predict nodal metastases in prostate cancer patients, potentially allowing a better selection of candidates to ePLND. KEY POINTS: • Multiparametric-MRI of the prostate can predict nodal metastases in prostate cancerTumour volume and stage at MRI are the most accurate predictors • Prevalence of nodal metastases is low for T2-stage and <1cc tumours • Preoperative mpMRI may allow a better selection of candidates to lymphadenectomy.

Entities:  

Keywords:  Lymph node dissection; Lymph nodes; Magnetic resonance imaging; Prostate cancer; Tumour volume

Mesh:

Year:  2017        PMID: 29270644     DOI: 10.1007/s00330-017-5229-6

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  29 in total

1.  Initial Experience of (68)Ga-PSMA PET/CT Imaging in High-risk Prostate Cancer Patients Prior to Radical Prostatectomy.

Authors:  Lars Budäus; Sami-Ramzi Leyh-Bannurah; Georg Salomon; Uwe Michl; Hans Heinzer; Hartwig Huland; Markus Graefen; Thomas Steuber; Clemens Rosenbaum
Journal:  Eur Urol       Date:  2015-06-25       Impact factor: 20.096

2.  Decreasing rate and extent of lymph node staging in patients undergoing radical prostatectomy may undermine the rate of diagnosis of lymph node metastases in prostate cancer.

Authors:  Firas Abdollah; Maxine Sun; Rodolphe Thuret; Lars Budäus; Claudio Jeldres; Markus Graefen; Alberto Briganti; Paul Perrotte; Patrizio Rigatti; Francesco Montorsi; Pierre I Karakiewicz
Journal:  Eur Urol       Date:  2010-09-28       Impact factor: 20.096

3.  The association of tumor volume with mortality following radical prostatectomy.

Authors:  J J Knoedler; R J Karnes; R H Thompson; L J Rangel; E J Bergstralh; S A Boorjian
Journal:  Prostate Cancer Prostatic Dis       Date:  2014-01-28       Impact factor: 5.554

4.  Correlation of magnetic resonance imaging tumor volume with histopathology.

Authors:  Baris Turkbey; Haresh Mani; Omer Aras; Ardeshir R Rastinehad; Vijay Shah; Marcelino Bernardo; Thomas Pohida; Dagane Daar; Compton Benjamin; Yolanda L McKinney; W Marston Linehan; Bradford J Wood; Maria J Merino; Peter L Choyke; Peter A Pinto
Journal:  J Urol       Date:  2012-08-15       Impact factor: 7.450

5.  Combined endorectal and phased-array MRI in the prediction of pelvic lymph node metastasis in prostate cancer.

Authors:  Liang Wang; Hedvig Hricak; Michael W Kattan; Lawrence H Schwartz; Steven C Eberhardt; Hui-Ni Chen; Peter T Scardino
Journal:  AJR Am J Roentgenol       Date:  2006-03       Impact factor: 3.959

6.  Metastases in normal-sized pelvic lymph nodes: detection with diffusion-weighted MR imaging.

Authors:  Harriet C Thoeny; Johannes M Froehlich; Maria Triantafyllou; Juerg Huesler; Lauren J Bains; Peter Vermathen; Achim Fleischmann; Urs E Studer
Journal:  Radiology       Date:  2014-06-02       Impact factor: 11.105

7.  Extended pelvic lymph node dissection in prostate cancer: a 20-year audit in a single center.

Authors:  F Abdollah; N Suardi; A Gallina; M Bianchi; M Tutolo; N Passoni; N Fossati; M Sun; P dell'Oglio; A Salonia; P I Karakiewicz; P Rigatti; F Montorsi; A Briganti
Journal:  Ann Oncol       Date:  2013-03-18       Impact factor: 32.976

8.  Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy.

Authors:  Martin C Schumacher; Fiona C Burkhard; George N Thalmann; Achim Fleischmann; Urs E Studer
Journal:  Eur Urol       Date:  2008-05-21       Impact factor: 20.096

9.  Prostate cancer: incremental value of endorectal MR imaging findings for prediction of extracapsular extension.

Authors:  Liang Wang; Michael Mullerad; Hui-Ni Chen; Steven C Eberhardt; Michael W Kattan; Peter T Scardino; Hedvig Hricak
Journal:  Radiology       Date:  2004-05-27       Impact factor: 11.105

10.  ESUR prostate MR guidelines 2012.

Authors:  Jelle O Barentsz; Jonathan Richenberg; Richard Clements; Peter Choyke; Sadhna Verma; Geert Villeirs; Olivier Rouviere; Vibeke Logager; Jurgen J Fütterer
Journal:  Eur Radiol       Date:  2012-02-10       Impact factor: 5.315

View more
  12 in total

1.  A comparison between 68Ga-labeled prostate-specific membrane antigen-PET/CT and multiparametric MRI for excluding regional metastases prior to radical prostatectomy.

Authors:  Michael Frumer; Nadav Milk; Gal Rinott Mizrahi; Sergiu Bistritzky; Itay Sternberg; Ilan Leibovitch; Yoram Dekel; Gilad E Amiel; Amnon Zisman; Jack Baniel; Miki Haifler; Jonathan Gal; Azik Hoffman; Itay Sagy; Barak Rosenzweig; Rennen Haramaty; Shay Golan
Journal:  Abdom Radiol (NY)       Date:  2020-07-15

Review 2.  Role of MRI in planning radical prostatectomy: what is the added value?

Authors:  Jose Marenco; Clement Orczyk; Tom Collins; Caroline Moore; Mark Emberton
Journal:  World J Urol       Date:  2019-04-15       Impact factor: 4.226

3.  Preoperative prediction of pelvic lymph nodes metastasis in prostate cancer using an ADC-based radiomics model: comparison with clinical nomograms and PI-RADS assessment.

Authors:  Xiang Liu; Xiangpeng Wang; Yaofeng Zhang; Zhaonan Sun; Xiaodong Zhang; Xiaoying Wang
Journal:  Abdom Radiol (NY)       Date:  2022-06-28

Review 4.  All change in the prostate cancer diagnostic pathway.

Authors:  Derek J Lomas; Hashim U Ahmed
Journal:  Nat Rev Clin Oncol       Date:  2020-02-28       Impact factor: 66.675

Review 5.  Multimodal Composite Iron Oxide Nanoparticles for Biomedical Applications.

Authors:  Shameer Pillarisetti; Saji Uthaman; Kang Moo Huh; Yang Seok Koh; Sangjoon Lee; In-Kyu Park
Journal:  Tissue Eng Regen Med       Date:  2019-10-01       Impact factor: 4.169

6.  Correlation of Prostate-Imaging Reporting and Data Scoring System scoring on multiparametric prostate magnetic resonance imaging with histopathological factors in radical prostatectomy material in Turkish prostate cancer patients: a multicenter study of the Urooncology Association.

Authors:  Fuat Kızılay; Serdar Çelik; Sinan Sözen; Bora Özveren; Saadettin Eskiçorapçı; Mahir Özgen; Haluk Özen; Bülent Akdoğan; Güven Aslan; Fehmi Narter; Çağ Çal; Levent Türkeri
Journal:  Prostate Int       Date:  2020-02-08

7.  External Validation and Comparison of Two Nomograms Predicting the Probability of Lymph Node Involvement in Patients subjected to Robot-Assisted Radical Prostatectomy and Concomitant Lymph Node Dissection: A Single Tertiary Center Experience in the MRI-Era.

Authors:  Nicola Frego; Marco Paciotti; Nicolò Maria Buffi; Davide Maffei; Roberto Contieri; Pier Paolo Avolio; Vittorio Fasulo; Alessandro Uleri; Massimo Lazzeri; Rodolfo Hurle; Alberto Saita; Giorgio Ferruccio Guazzoni; Paolo Casale; Giovanni Lughezzani
Journal:  Front Surg       Date:  2022-02-25

Review 8.  Current Opinion on the Use of Magnetic Resonance Imaging in Staging Prostate Cancer: A Narrative Review.

Authors:  Jamie Michael; Kevin Neuzil; Ersan Altun; Marc A Bjurlin
Journal:  Cancer Manag Res       Date:  2022-03-01       Impact factor: 3.989

9.  Incorporating mpMRI biopsy data into established pre-RP nomograms: potential impact of an increasingly common clinical scenario.

Authors:  Joon Yau Leong; Jaime O Herrera-Caceres; Hanan Goldberg; Elwin Tham; Seth Teplitsky; Leonard G Gomella; Neil E Fleshner; Costas D Lallas; Edouard J Trabulsi; Thenappan Chandrasekar
Journal:  Ther Adv Urol       Date:  2019-10-13

10.  A Genomic-Clinicopathologic Nomogram for the Prediction of Lymph Node Invasion in Prostate Cancer.

Authors:  Zongtai Zheng; Shiyu Mao; Zhuoran Gu; Ruiliang Wang; Yadong Guo; Wentao Zhang; Xudong Yao
Journal:  J Oncol       Date:  2021-05-26       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.